findmyKOL
Clinical trialNCT04663997Active, not recruitingPhase 2Interventional

177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer

SponsorCanadian Cancer Trials GroupEnrollment200Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Tom Baker Cancer Centre

    Calgary, Alberta, Canada

  • Cross Cancer Institute

    Edmonton, Alberta, Canada

  • Bcca - Vancouver Cancer Centre

    Vancouver, British Columbia, Canada

  • London Regional Cancer Program

    London, Ontario, Canada

  • Odette Cancer Centre

    Toronto, Ontario, Canada

  • University Health Network

    Toronto, Ontario, Canada

  • Chum-Centre Hospitalier de L'Universite de Montreal

    Montreal, Quebec, Canada

  • the Jewish General Hospital

    Montreal, Quebec, Canada

  • Hotel-Dieu de Quebec

    Québec, Quebec, Canada

  • Ciusss de L'Estrie - Centre Hospitalier

    Sherbrooke, Quebec, Canada

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Vipivotide tetraxetan →Docetaxel →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
11 Aug 2021
Primary completion
25 Aug 2025
Completion
31 Dec 2026
Last update posted
27 Mar 2026
Registered enrollment
200
Registry id
NCT04663997
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.